Results 71 to 80 of about 469 (131)

Combined Use of Remimazolam and Ciprofol Reduces Hypoxemia and Shortens Recovery Time During Sedated Gastrointestinal Endoscopy

Drug Design, Development and Therapy
Hypoxemia is the most common adverse event during painless gastrointestinal endoscopy (PGIE). This study aimed to evaluate whether the combined use of remimazolam besylate and ciprofol (group RC) reduces the incidence of hypoxemia compared to ciprofol alone (group C) in patients undergoing PGIE under deep sedation.A total of 246 patients scheduled for ...
Hai-Ding Zou, Cong Luo, Zhao-Lan Hu, Pei Zhou, Ru-Yi Luo   +4 more
openaire   +2 more sources

Incidence of respiratory depression between ciprofol and propofol after anesthesia: A systematic review and meta-analysis

Medicine
Background: Respiratory depression is a common complication during operative procedures, meanwhile, ciprofol can provide effective sedation for surgical operations. However, there is not enough evidence to prove the advantage of ciprofol in reducing respiratory depression.
Jinfang Zeng, Qian Cao, Aonan Hong, Zhen Gu, Jinjin Jian, Xiao Liang   +5 more
openaire   +2 more sources

Effects of ciprofol on hemodynamics and cerebral protection in patients undergoing meningioma resection

Medicine
Background: Meningiomas are common intracranial tumors. Surgery remains the primary therapy. The purpose of this study was to investigate the effects of ciprofol on hemodynamics and cerebral protection in patients undergoing meningioma resection. Methods:
Chengwei Tan, Mo Li
openaire   +2 more sources

Efficacy and safety of ciprofol for general anesthesia induction in female patients with frailty: a prospective randomized controlled trial

BMC Anesthesiology
Background Ciprofol, a recently developed anesthetic agent, is not inferior to propofol in terms of efficacy and safety. However, most previous clinical experience with ciprofol was based on a robust population.
Yu Wei, Lijie Jia, Shiping Cheng, Wei Ma, Xiaohu An, Zifeng Xu   +5 more
doaj   +1 more source

The Median Effective Dose of Ciprofol Combined with Sufentanil for Inhibiting Responses to Gastroscope Insertion in Obese Patients: A Prospective, Single-Center Study

Drug Design, Development and Therapy
Zhouya Xue,1,2,* Xiang Liu,1,2,* Weisheng Qian,1 Nan Yang,1 Yongyi Pan,1 Yong Zhou,1 Wei Jiang,1 Feng Li,1 Bin Qian1 1Department of Anesthesiology, The First People’s Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical ...
Xue Z, Liu X, Qian W, Yang N, Pan Y, Zhou Y, Jiang W, Li F, Qian B   +8 more
doaj  

Efficacy and safety of remimazolam besylate and ciprofol in painless gastrointestinal endoscopy in the elderly

Acta Cirúrgica Brasileira
This study aimed to ascertain the efficacy and safety of remimazolam besylate and ciprofol in elderly patients undergoing painless gastrointestinal endoscopy.Patients in the control group (n = 31) were anesthetized with ciprofol, and those in the observation group (n = 31) were anesthetized with remimazolam besylate.
openaire   +3 more sources

Ciprofol Ameliorates Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through Upregulating HIF-1α

Drug Design, Development and Therapy
Jun Ding,1– 3,* Bi-Ying Wang,1,2,* Yu-Fan Yang,1,2,* Ling-Yu Kuai,1,2 Jing-jie Wan,1,2 Mian Zhang,1,2 Hai-Yan Xia,3 Yao Wang,3 Zhong Zheng,3 Xiao-Wen Meng,1,2 Ke Peng,1,2 Fu-Hai Ji1,2 1Department of Anesthesiology, First Affiliated Hospital ...
Ding J, Wang BY, Yang YF, Kuai LY, Wan JJ, Zhang M, Xia HY, Wang Y, Zheng Z, Meng XW, Peng K, Ji FH   +11 more
doaj  

Ciprofol-associated Pink Urine

European Journal of Anaesthesiology
Xu, Lin, Yang, Fan, Zhu, Xing, Wei, Penghui   +3 more
openaire   +1 more source

Ciprofol attenuates cerebral Ischemia‒reperfusion injury in rats by inhibiting ferroptosis through upregulating AMPK. [PDF]

Sci Rep
Zeng H, Yu X, Zheng Z, Wang Z, Dong W, Gan J.   +5 more
europepmc   +1 more source

Efficacy and Safety of Ciprofol for Sedation in Critically Ill Patients After Cardiac Surgery: A Single-Center, Prospective, Randomized Controlled Trial. [PDF]

Drug Des Devel Ther
Guo L, Hong M, Li P, Du W, Li Y, Li J.
europepmc   +1 more source